
© 2024 Moneycab
Realtime | Geld | Brief | Zeit |
---|---|---|---|
280,90 | 281,40 | 03.04. | |
280,45 | 282,15 | 03.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Citi maintains Amgen stock Neutral rating, $295 target | ||
Do | Amgen got expanded FDA label approval for Uplizna | ||
Do | Amgen stock rises following FDA approval of UPLIZNA | ||
Mi | P/E Ratio Insights for Amgen | ||
Di | Amgen Options Trading: A Deep Dive into Market Sentiment |